Dead rat in hotpot report sends China restaurant shares sliding
[HONG KONG] A Chinese restaurant operator is in hot water after local media reported that a customer discovered a dead rat in a meal.
Shares of Xiabuxiabu Catering Management China Holdings Co. tumbled 11 percent in Hong Kong on Tuesday, extending Monday's 6.1 per cent decline. Authorities in Weifang city, in east China's Shandong province, are conducting food safety checks at one of Xiabuxiabu's restaurants there. Local website Weifang.sdnews.com reported after the market closed Friday that a customer found the rat in a hotpot meal on Sept. 6.
In a Sept. 8 statement on social media site Weibo, Xiabuxiabu said its own preliminary investigation ruled out the possibility the rat ended in the meal due to restaurant hygiene or operational reasons. The statement has since been deleted. Authorities have ordered the restaurant to suspend operations, according to a statement on their official WeChat account, which also said the restaurant faces penalties, without elaborating.
While there's never a good time to find a rat in your meal, this comes just as Xiabuxiabu becomes eligible for trading by mainland investors via the stock connect link between Shenzhen and Hong Kong. The Shenzhen Stock Exchange announced the changes on Monday.
Xiabuxiabu's shares have now tumbled 16 percent since Monday morning, their biggest two-day loss since July 2015. The company didn't immediately respond to a request for comment.
BLOOMBERG
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Jim Beam owner bets on canned vodka cocktails to double revenue
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Cordlife served letter of demand, notice of claim from customers
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs